You are here: Industry Insights > CMA

News List

Pfizer, Flynn accused of charging the NHS 'unfairly high prices' for anti-epilepsy drug pharmatimes
August 09, 2021
Pfizer and Flynn have been accused of breaking competition law by overcharging the NHS for ‘vital’ anti-epilepsy drugs, according to provisional findings from the UK Competition and Markets Authority (CMA).
CMA fines Advanz over ‘excessive and unfair’ pricing of thyroid drug pharmatimes
August 06, 2021
The Competition and Markets Authority (CMA) in the UK has found that pharma company Advanz charged ‘excessive and unfair’ prices for supplying liothyronine tablets, a common medication used to treat thyroid hormone deficiency.
Over £100mn in fines for pharma firms hiking prices of crucial thyroid drug europeanpharmaceuticalreview
July 30, 2021
The Competition and Markets Authority fines Advanz and two others for hiking prices of liothyronine tablets by 1,110 percent in eight years.
Competition and Markets Authority investigating AstraZeneca’s Alexion acquisition europeanpharmaceuticalreview
May 31, 2021
The UK’s competition authority will assess whether AstraZeneca’s acquisition of Alexion will result in a “substantial lessening of competition”.
Pfizer, BioNTech seek CMA expansion for Covid-19 vaccine in EU pharmaceutical-technology
May 06, 2021
Pfizer and BioNTech have submitted a request to the European Medicines Agency (EMA) to expand Conditional Marketing Authorization (CMA) of their Covid-19 vaccine, COMIRNATY (BNT162b2), in the European Union (EU) for use in adolescents aged 12 to 15 years.
Federal Trade Commission forms multilateral working group on pharma mergers pharmaceutical-technology
March 18, 2021
The US Federal Trade Commission (FTC) has launched a multilateral working group with domestic and international partners to reassess their approach to analysing the impacts of mergers and acquisitions (M&A) in the pharmaceutical industry.
Tribunal upholds CMA’s decision to fine Lexon £1.2m pharmatimes
March 02, 2021
The Competition Appeal Tribunal (CAT) has maintained a decision made last year by the UK’s Competition and Markets Authority (CMA) to fine pharmaceutical firm Lexon £1.2m after finding the company guilty of breaking competition law.
EMA receives authorisation application for AstraZeneca COVID-19 vaccine europeanpharmaceuticalreview
January 13, 2021
The EMA has received a conditional marketing authorisation application for the Oxford-AstraZeneca COVID-19 vaccine.
Moderna Covid-19 vaccine receives European Commission authorisation pharmaceutical-technology
January 08, 2021
The European Commission has granted a conditional marketing authorisation (CMA) to COVID-19 Vaccine Moderna for active immunisation to prevent the disease in individuals aged 18 years and above.
Pfizer and BioNTech get EU authorisation for COVID-19 Vaccine expresspharma
December 22, 2020
Pfizer and BioNTech announced that the European Commission (EC) has granted a conditional marketing authorisation (CMA) to Pfizer and BioNTech for COMIRNATY (also known as BNT162b2), for active immunisation to prevent COVID-19 caused by SARS-CoV-2 ...

Previous page 1 2 3 Next page